Primecap Management’s Amicus Therapeutics FOLD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.56M | Sell |
796,100
-123,400
| -13% | -$707K | ﹤0.01% | 287 |
|
|
2025
Q1 | $7.5M | Sell |
919,500
-15,300
| -2% | -$125K | 0.01% | 266 |
|
|
2024
Q4 | $8.81M | Sell |
934,800
-94,000
| -9% | -$885K | 0.01% | 258 |
|
|
2024
Q3 | $11M | Sell |
1,028,800
-23,700
| -2% | -$253K | 0.01% | 258 |
|
|
2024
Q2 | $10.4M | Sell |
1,052,500
-41,700
| -4% | -$414K | 0.01% | 256 |
|
|
2024
Q1 | $12.9M | Hold |
1,094,200
| – | – | 0.01% | 251 |
|
|
2023
Q4 | $15.5M | Hold |
1,094,200
| – | – | 0.01% | 240 |
|
|
2023
Q3 | $13.3M | Hold |
1,094,200
| – | – | 0.01% | 246 |
|
|
2023
Q2 | $13.7M | Sell |
1,094,200
-59,200
| -5% | -$744K | 0.01% | 246 |
|
|
2023
Q1 | $12.8M | Hold |
1,153,400
| – | – | 0.01% | 244 |
|
|
2022
Q4 | $14.1M | Sell |
1,153,400
-174,800
| -13% | -$2.13M | 0.01% | 235 |
|
|
2022
Q3 | $13.9M | Hold |
1,328,200
| – | – | 0.01% | 229 |
|
|
2022
Q2 | $14.3M | Sell |
1,328,200
-100,400
| -7% | -$1.08M | 0.01% | 234 |
|
|
2022
Q1 | $13.5M | Sell |
1,428,600
-99,400
| -7% | -$941K | 0.01% | 250 |
|
|
2021
Q4 | $17.6M | Sell |
1,528,000
-98,100
| -6% | -$1.13M | 0.01% | 247 |
|
|
2021
Q3 | $15.5M | Sell |
1,626,100
-218,900
| -12% | -$2.09M | 0.01% | 252 |
|
|
2021
Q2 | $17.8M | Sell |
1,845,000
-285,000
| -13% | -$2.75M | 0.01% | 242 |
|
|
2021
Q1 | $21M | Hold |
2,130,000
| – | – | 0.01% | 236 |
|
|
2020
Q4 | $49.2M | Hold |
2,130,000
| – | – | 0.04% | 190 |
|
|
2020
Q3 | $30.1M | Hold |
2,130,000
| – | – | 0.02% | 194 |
|
|
2020
Q2 | $32.1M | Sell |
2,130,000
-131,000
| -6% | -$1.98M | 0.03% | 183 |
|
|
2020
Q1 | $20.9M | Sell |
2,261,000
-34,000
| -1% | -$314K | 0.02% | 189 |
|
|
2019
Q4 | $22.4M | Buy |
2,295,000
+97,500
| +4% | +$950K | 0.02% | 208 |
|
|
2019
Q3 | $17.6M | Buy |
+2,197,500
| New | +$17.6M | 0.01% | 208 |
|